Core Points - The candidate HE RUYI has been nominated by Shenzhen Keyi Pharmaceutical Holdings Co., Ltd. as an independent director candidate for the third board of directors of Sinovac Biotech Ltd. [1] - The candidate declares that they possess the necessary qualifications and independence to serve as an independent director, ensuring no relationships that could affect their independence exist [1][4] - The candidate has over five years of relevant work experience in law, economics, accounting, finance, and management, which is essential for fulfilling the responsibilities of an independent director [1] - The candidate confirms compliance with various legal and regulatory requirements regarding the qualifications for independent directors, including the Company Law of the People's Republic of China and relevant regulations from the China Securities Regulatory Commission [1] - The candidate asserts independence by stating they do not fall under specific disqualifying conditions, such as holding significant shares in the company or having close relationships with major shareholders [1][3] - The candidate has no adverse records, including administrative or criminal penalties from the China Securities Regulatory Commission in the last 36 months [2][3] - The candidate has not been disqualified from serving as an independent director due to previous attendance issues at board meetings [3] - The candidate has participated in training and obtained relevant certification recognized by the stock exchange [6] - The candidate commits to adhering to laws, regulations, and rules set forth by the China Securities Regulatory Commission and the Shanghai Stock Exchange during their tenure [4]
科兴制药: 独立董事候选人声明与承诺(HE RUYI)